跳至主要内容
临床试验/NCT00502398
NCT00502398Unknown不适用

Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?

Rabin Medical Center1 个研究点 分布在 1 个国家开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
不适用
试验地点
1

研究概览

简要总结

Patients with hemolytic disorders (e.g. sickle cell anemia or thalassemia) are known to develop pulmonary hypertension. Hemolysis is where red blood cells are destroyed and their contents released into the circulation. It is thought that these red-cell contents cause constriction and thrombosis of the blood vessels in the lungs. Conversely, it is possible that patients with pulmonary hypertension have hemolysis.

In this study we will be drawing blood from a range of patients and normal controls for a panel of blood tests related to hemolysis.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • One of the following four conditions :
  • Pulmonary artery hypertension
  • Obstructive sleep apnea with pulmonary hypertension
  • Lung transplant candidates without pulmonary hypertension
  • Normal Controls

排除标准

  • Known hemolytic disorder
  • Recent blood loss (<3 months)
  • Recent blood transfusion (<3 months)
  • Liver disease

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验